Clinical Trials Browser

Phase 1/2 × INDUSTRY × Advanced Non-small Cell Lung Cancer × Clear all

NCT05099172 2026-03-12

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

Phase 1/2 Active not recruiting

370 enrolled 1 FDA

Advanced Non-small Cell Lung Cancer

NCT02108964 2024-12-11

A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies

Phase 1/2 Completed

225 enrolled 31 charts

Advanced Non-small Cell Lung Cancer

NCT04818333 2024-06-13

A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer

Phase 1/2 Active not recruiting

Advanced Non-small Cell Lung Cancer

NCT06434103 2024-05-30

Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC

Phase 1/2 Not yet recruiting

Advanced Non-small Cell Lung Cancer

NCT05482568 2023-10-16

A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer

Phase 1/2 Unknown

Advanced Non-small Cell Lung Cancer

NCT05416775 2022-08-19

Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer

Phase 1/2 Recruiting

Advanced Non-small Cell Lung Cancer